Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • CA125
Dual Biomarker Strategy: Enhancing Prognosis in Acute Heart Failure with CA125 and NT-proBNP in Vietnam
Posted inClinical Updates Wellness & Lifestyle

Dual Biomarker Strategy: Enhancing Prognosis in Acute Heart Failure with CA125 and NT-proBNP in Vietnam

Posted by By MedXY 08/08/2025
Combining CA125 with NT-proBNP significantly improves prediction of cardiovascular and all-cause mortality, as well as rehospitalization risk in patients with acute heart failure.
Read More
  • Ashwagandha Supplementation for Cognitive Enhancement: Evidence from MCI and Healthy Populations
  • Quercetin as an Adjunct for Post-Cesarean Pain: Clinical Promise from a Randomized Controlled Trial
  • Medium‑Chain Triglyceride–Supplemented Ketogenic Diet in Parkinson’s Disease: A Small Randomized Feasibility Trial and What It Means for Clinical Practice
  • Ketogenic Diet vs Further Antiseizure Medication in Infants with Drug-Resistant Epilepsy: What the KIWE Trial Adds to Clinical Practice
  • Assessing the Impact of a Ketogenic Diet in Critically Ill Sepsis Patients: An Open-Label Randomized Controlled Trial
  • About us
  • Contact us
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence blood pressure breast cancer cardiovascular health clinical trial clinical trials COPD Dementia diabetes diet dinh dưỡng epidemiology exercise health healthcare Hypertension immunotherapy ketogenic diet lifestyle longevity MASLD men's health mental health multiple myeloma NAFLD nutrition obesity phòng ngừa Pregnancy prevention public health randomized controlled trial randomized trial sexual health sleep sức khỏe Sức khỏe phụ nữ treatment type 2 diabetes Vaccine weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top